← back to search

Norbert Suttorp

German Center for Lung Research · DE
Area of research
Epidemiology · Immunology
Research interest
Research interests include Pneumonia and Respiratory Infections, Immune Response and Inflammation, Respiratory viral infections research, and COVID-19 Clinical Research Studies.
h-index
88
citations
29,751
works
752
NIH funding
primary concept
Medicine
email

Recent publications

Predicting the Risk of Intensive Care Unit Admission in Patients With COVID-19 Presenting in the Emergency Room: Development and Evaluation of the Confusion, Respiratory Rate, Oxygen Saturation With or Without Concurrent Supplemental Oxygen, and Oxygen Supplementation Score
Clinical Infectious Diseases 2025cited by 2position: middledoi
Community-acquired pneumonia in diabetic patients is characterised by a distinct pathogen spectrum and enhanced inflammation: results from CAPNETZ, a prospective observational cohort study
Infection 2025cited by 1position: middledoi
Predicting the Risk of Intensive Care Unit Admission in Patients With COVID-19 Presenting in the Emergency Room: Development and Evaluation of the Confusion, Respiratory Rate, Oxygen Saturation With or Without Concurrent Supplemental Oxygen, and Oxygen Supplementation Score.
2025cited by 1position: contributordoi
The life-saving benefit of dexamethasone in severe COVID-19 is linked to a reversal of monocyte dysregulation
Cell 2024cited by 27position: middledoi
Gut microbiota dysbiosis is associated with altered tryptophan metabolism and dysregulated inflammatory response in COVID-19
npj Biofilms and Microbiomes 2024cited by 25position: middledoi
Gut microbiota dysbiosis is associated with altered tryptophan metabolism and dysregulated inflammatory response in COVID-19.
2024cited by 22position: contributordoi
The life-saving benefit of dexamethasone in severe COVID-19 is linked to a reversal of monocyte dysregulation.
2024cited by 20position: contributordoi
Resurgence of common respiratory viruses in patients with community-acquired pneumonia (CAP)—A prospective multicenter study
Journal of Clinical Virology 2024cited by 19position: middledoi
IL-33 controls IL-22-dependent antibacterial defense by modulating the microbiota
Proceedings of the National Academy of Sciences 2024cited by 11position: middledoi
Pathogen spectrum of community acquired pneumonia in people living with HIV (PLWH) in the German CAPNETZ-Cohort.
2024cited by 7position: contributordoi
Comparison of clinical outcomes in hospitalized patients with COVID-19 or non-COVID-19 community-acquired pneumonia in a prospective observational cohort study
Infection 2024cited by 4position: middledoi
Comparison of clinical outcomes in hospitalized patients with COVID-19 or non-COVID-19 community-acquired pneumonia in a prospective observational cohort study.
2024cited by 2position: contributordoi
Activin A levels are raised during human tuberculosis and blockade of the activin signaling axis influences murine responses to <i>M. tuberculosis</i> infection.
2024cited by 2position: contributordoi
Analysis of acute COVID-19 including chronic morbidity: protocol for the deep phenotyping National Pandemic Cohort Network in Germany (NAPKON-HAP).
2024cited by 2position: contributordoi
Hepatobiliary long-term consequences of COVID-19: dramatically increased rate of secondary sclerosing cholangitis in critically ill COVID-19 patients
Hepatology International 2023cited by 23position: middledoi
Surface proteome of plasma extracellular vesicles as mechanistic and clinical biomarkers for malaria
Infection 2023cited by 15position: middledoi
Surface proteome of plasma extracellular vesicles as mechanistic and clinical biomarkers for malaria.
2023cited by 13position: contributordoi
MicroRNA-223 Dampens Pulmonary Inflammation during Pneumococcal Pneumonia
Cells 2023cited by 12position: middledoi
Pathogen spectrum of community acquired pneumonia in people living with HIV (PLWH) in the German CAPNETZ-Cohort
Infection 2023cited by 11position: middledoi
Cenicriviroc for the treatment of COVID-19: first interim results of a randomised, placebo-controlled, investigator-initiated, double-blind phase II trial.
2023cited by 9position: contributordoi
Novel protein biomarkers for pneumonia and acute exacerbations in COPD: a pilot study
Frontiers in Medicine 2023cited by 7position: middledoi
Novel protein biomarkers for pneumonia and acute exacerbations in COPD: a pilot study.
2023cited by 5position: contributordoi
Analysis of acute COVID-19 including chronic morbidity: protocol for the deep phenotyping National Pandemic Cohort Network in Germany (NAPKON-HAP)
Infection 2023cited by 4position: middledoi
MicroRNA-223 Dampens Pulmonary Inflammation during Pneumococcal Pneumonia.
2023cited by 4position: contributordoi
Cystic fibrosis transmembrane conductance regulator modulators attenuate platelet activation and aggregation in blood of healthy donors and COVID-19 patients
European Respiratory Journal 2023cited by 1position: middledoi
Cystic fibrosis transmembrane conductance regulator modulators attenuate platelet activation and aggregation in blood of healthy donors and COVID-19 patients.
2023cited by 0position: contributordoi
Complement activation induces excessive T cell cytotoxicity in severe COVID-19.
2022cited by 172position: contributordoi
Severity of respiratory failure and computed chest tomography in acute COVID-19 correlates with pulmonary function and respiratory symptoms after infection with SARS-CoV-2: An observational longitudinal study over 12 months.
2022cited by 76position: contributordoi
ADAM8 signaling drives neutrophil migration and ARDS severity
JCI Insight 2022cited by 61position: middledoi
Human lungs show limited permissiveness for SARS-CoV-2 due to scarce ACE2 levels but virus-induced expansion of inflammatory macrophages
European Respiratory Journal 2022cited by 59position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Martin Witzenrath · German Centre for Cardiovascular Research31 papers (2015–2023)Florian Kurth · Swiss Center for Electronics and Microtechnology (Switzerland)31 papers (2019–2025)Gernot Rohde · Ophthalmology Clinic16 papers (2012–2024)Victor M. Corman · University of Edinburgh14 papers (2020–2024)Thomas Zöller · Humboldt-Universität zu Berlin14 papers (2019–2025)Stefan Hippenstiel · Helios Klinikum Emil von Behring12 papers (2018–2023)Leif Erik Sander · Charité - Universitätsmedizin Berlin11 papers (2017–2022)Christof von Kalle · Luxembourg Institute of Health9 papers (2020–2024)Markus Scholz · Ludwigsburg University of Education9 papers (2019–2023)Achim D. Gruber · Technische Universität Berlin9 papers (2017–2023)Jan Rupp · University Medical Center Utrecht8 papers (2015–2024)Florian Kurth · Swiss Center for Electronics and Microtechnology (Switzerland)8 papers (2020–2022)Bastian Opitz · Humboldt-Universität zu Berlin8 papers (2019–2024)Wolfgang M. Kuebler · Xinqiao Hospital8 papers (2020–2023)Andreas C. Hocke · German Center for Lung Research8 papers (2015–2022)Bastian Opitz · Humboldt-Universität zu Berlin8 papers (2017–2022)Wolfgang M. Kuebler · University of Toronto7 papers (2015–2022)Tobias Welte · University of Haifa7 papers (2012–2021)Matthias Raspe · Charité - Universitätsmedizin Berlin7 papers (2018–2022)Christian Meisel · University of Zurich7 papers (2020–2024)